Merck KGaA Earnings, Sales Grew in 2Q
04 Agosto 2022 - 3:06AM
Dow Jones News
By Cecilia Butini
Merck KGaA on Thursday posted growing earnings and sales for the
second quarter, which it said were driven by all divisions and
boosted by positive currency effects.
The German pharmaceuticals-and-chemicals company posted
after-tax profit of 870 million euros ($884.5 million), up from
EUR747 million the year prior, on sales which grew to EUR5.57
billion from EUR4.87 billion.
Earnings before interest, taxes, depreciation and amortization
before one-time items, known as Ebitda pre--a closely watched
metric--came in at EUR1.78 billion, up from EUR1.58 billion, Merck
said.
Sales growth was positively affected by foreign-exchange
effects, especially due to developments in the U.S. dollar, the
Chinese yuan and the Taiwanese dollar, the company said.
Merck backed its guidance on sales and Ebitda pre growth for the
full year. It said it continues to expect sales growth of between
6% to 9%, and Ebitda pre growth of 5% to 9%.
However, strong positive currency effects are expected to help
lift full-year results in these two metrics, Merck said. The
company now expects full-year sales of between EUR21.9 billion and
EUR23 billion, and Ebitda pre of between EUR6.75 billion and
EUR7.25 billion. It had previously guided for net sales between
EUR21.6 billion and EUR22.8 billion, and Ebitda pre between EUR6.6
billion and EUR7.1 billion.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
August 04, 2022 01:51 ET (05:51 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Merck KGAA (TG:MRK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024